Tabunda, Junelyn .

HRN: 10-82-69  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/21/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/21/2026
05/22/2026
IV
900mg
Q8hrs
S/P LSTCS
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: